Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00139204 · ClinicalTrials.gov registry record · NA

Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients

A NA study, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT00139204: Completed NA study, sponsored by Dana-Farber Cancer Institute.

NCT00139204 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00139204, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this study is to better understand a new type of radiology test called positron emission tomography (PET) with carbon 11 methionine to determine which patients have a beneficial effect from anti-cancer therapy with the drug docetaxel.

Interventions

  • PROCEDURE C11 Methionine PET scan

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2005-04
Est. Completion 2006-07
Phase NA
Dana-Farber Cancer Institute

781 total trials

What the finished NCT00139204 record still lists

NCT00139204 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which C11 Methionine PET scan is the first listed.

NCT00139204 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00139204 about?

NCT00139204 is a clinical study titled "Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients". The purpose of this study is to better understand a new type of radiology test called positron emission tomography (PET) with carbon 11 methionine to determine which patients have a beneficial effect from anti-cancer therapy with the drug docetaxel.

What is the current status of trial NCT00139204?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2005-04. Estimated completion is 2006-07.

What interventions are being tested in trial NCT00139204?

The interventions under investigation include: C11 Methionine PET scan (PROCEDURE).

Who is sponsoring clinical trial NCT00139204?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00139204's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00139204, the US trial registry maintained by the National Library of Medicine. NCT00139204 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.